©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Feb 15, 2015; 7(2): 6-11
Published online Feb 15, 2015. doi: 10.4251/wjgo.v7.i2.6
Published online Feb 15, 2015. doi: 10.4251/wjgo.v7.i2.6
Radiofrequency ablation of pancreatic ductal adenocarcinoma: The past, the present and the future
Garvi J Pandya, Medicine, Ministry of Health Holdings Pte Ltd, Singapore 308433, Singapore
Vishal G Shelat, Division of Hepato-pancreatico-biliary Surgery, Tan Tock Seng Hospital, Singapore 308433, Singapore
Author contributions: Pandya GJ and Shelat VG contributed equally to this work, generated the figures and wrote the manuscript.
Conflict-of-interest: None to declare.
Correspondence to: Vishal G Shelat, FRCS, FICS, Consultant Surgeon, Division of Hepato-pancreatico-biliary Surgery, Tan Tock Seng Hospital, 11, Jalan Tan Tock Seng, Singapore 308433, Singapore. vgshelat@rediffmail.com
Telephone: +65-63577807 Fax: +65-63577809
Received: October 4, 2014
Peer-review started: October 5, 2014
First decision: November 3, 2014
Revised: November 10, 2014
Accepted: December 29, 2014
Article in press: December 31, 2014
Published online: February 15, 2015
Processing time: 119 Days and 7.4 Hours
Peer-review started: October 5, 2014
First decision: November 3, 2014
Revised: November 10, 2014
Accepted: December 29, 2014
Article in press: December 31, 2014
Published online: February 15, 2015
Processing time: 119 Days and 7.4 Hours
Core Tip
Core tip: Radiofrequency ablation of pancreatic cancer is rapidly emerging as an attractive adjunct in locally advanced inoperable disease and is a part of modern multimodal hepatobiliary teams. Due to technological advances, refinements in thermokinetic principles and ongoing advances in medicinal oncology; it is likely that the role of radiofrequency in management of pancreatic cancer is going to increase in future. In this article we summarize the current evidence of application of radiofrequency ablation in pancreatic cancer.